Studies on the Metabolic Fate of Flutamide (3) : Absorption, Distribution and Excretion following Consecutive Oral Administration in Rats

Pharmacokinetic studies of Flutamide were performed in rats. Blood and plasma levels, tissue distribution and excretion of Flutamide were examined during and after the consecutive oral administration of 14C-Flutamide at a daily dose of 5 mg/kg for 21 days. 1. The blood levels of radioactivity at 24...

Full description

Saved in:
Bibliographic Details
Published inDrug Metabolism and Pharmacokinetics Vol. 10; no. 4; pp. 464 - 469
Main Authors ASAKAWA, Noriko, KOYAMA, Michinori, HONDA, Naoko, HASHIMOTO, Yutaka, SEKI, Hideaki, HARADA, Tomoko, YAMASHITA, Kouwa, ESUMI, Yoshio, TAKAICHI, Matsuo
Format Journal Article
LanguageEnglish
Published The Japanese Society for the Study of Xenobiotics 1995
Subjects
Online AccessGet full text
ISSN0916-1139
DOI10.2133/dmpk.10.464

Cover

Abstract Pharmacokinetic studies of Flutamide were performed in rats. Blood and plasma levels, tissue distribution and excretion of Flutamide were examined during and after the consecutive oral administration of 14C-Flutamide at a daily dose of 5 mg/kg for 21 days. 1. The blood levels of radioactivity at 24 hr after daily dosing increased with the number of dose, reaching the steady state on day 16. 2. The radioactivity was well distributed in all the tissues following the consecutive oral doses. The concentrations in the blood, small intestine, kidney, spleen, preputinal gland, stomach and the liver were 4.4 ?? 6.0 times higher than those after a single dosing, and that in the other tissues were 2.6 ?? 3.8 times higher. The radioactivity in most tissues after the final dosing was eliminated slowly from the tissues. 3. Excretion rates of radioactivity into urine and feces were 68.2 and 24.6% at 120 hr after the final dosing, respectively. These were almost constant duringthe consecutive oral doses. Residual radioactivity in rats was 0.6% of the total doses.
AbstractList Pharmacokinetic studies of Flutamide were performed in rats. Blood and plasma levels, tissue distribution and excretion of Flutamide were examined during and after the consecutive oral administration of 14C-Flutamide at a daily dose of 5 mg/kg for 21 days. 1. The blood levels of radioactivity at 24 hr after daily dosing increased with the number of dose, reaching the steady state on day 16. 2. The radioactivity was well distributed in all the tissues following the consecutive oral doses. The concentrations in the blood, small intestine, kidney, spleen, preputinal gland, stomach and the liver were 4.4 ?? 6.0 times higher than those after a single dosing, and that in the other tissues were 2.6 ?? 3.8 times higher. The radioactivity in most tissues after the final dosing was eliminated slowly from the tissues. 3. Excretion rates of radioactivity into urine and feces were 68.2 and 24.6% at 120 hr after the final dosing, respectively. These were almost constant duringthe consecutive oral doses. Residual radioactivity in rats was 0.6% of the total doses.
Author HASHIMOTO, Yutaka
KOYAMA, Michinori
TAKAICHI, Matsuo
HONDA, Naoko
ASAKAWA, Noriko
YAMASHITA, Kouwa
ESUMI, Yoshio
HARADA, Tomoko
SEKI, Hideaki
Author_xml – sequence: 1
  fullname: ASAKAWA, Noriko
  organization: Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd
– sequence: 1
  fullname: KOYAMA, Michinori
  organization: Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd
– sequence: 1
  fullname: HONDA, Naoko
  organization: Tokai Research Laboratories, Daiichi Pure Chemicals Co, Ltd
– sequence: 1
  fullname: HASHIMOTO, Yutaka
  organization: Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd
– sequence: 1
  fullname: SEKI, Hideaki
  organization: Tokai Research Laboratories, Daiichi Pure Chemicals Co, Ltd
– sequence: 1
  fullname: HARADA, Tomoko
  organization: Tokai Research Laboratories, Daiichi Pure Chemicals Co, Ltd
– sequence: 1
  fullname: YAMASHITA, Kouwa
  organization: Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd
– sequence: 1
  fullname: ESUMI, Yoshio
  organization: Tokai Research Laboratories, Daiichi Pure Chemicals Co, Ltd
– sequence: 1
  fullname: TAKAICHI, Matsuo
  organization: Tokai Research Laboratories, Daiichi Pure Chemicals Co, Ltd
BookMark eNo9kMtOwzAQRb0oEqV0xQ94CYIUO3aTmF3VByCBKvFYR44zaV0Su7JdHp_AX5O0qLOY0dWcmdGdM9Qz1gBCF5SMYsrYbdlsP0at4AnvoT4RNIkoZeIUDb3fEEJYzBLCx330-xp2pQaPrcFhDfgZgixsrRVeyADYVnhR74JsdAn4kl3hOzwpvHXboK25wTPtg9PFrlNYmhLPv5WDvapsXdsvbVZ4ao0H1TKfgJdO1nhSNtp0k3JPaoNfZPDn6KSStYfhfx2g98X8bfoQPS3vH6eTp0hRQXmUQhtZ60ulXKZKljEZQ1akQqWFKEWckKrg6Zh3_ihXSpIiEzJjhRCcE0jZAF0f9ipnvXdQ5VunG-l-ckry7nl597xOtEdaenagNz7IFRxZ6YJWNexZKrJkzx9SO3Zsq7V0ORj2B1l7f_Y
ContentType Journal Article
Copyright The Japanese Society for the Study of Xenobiotics
Copyright_xml – notice: The Japanese Society for the Study of Xenobiotics
DBID AAYXX
CITATION
DOI 10.2133/dmpk.10.464
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EndPage 469
ExternalDocumentID 10_2133_dmpk_10_464
article_dmpk1986_10_4_10_4_464_article_char_en
GroupedDBID 2WC
53G
ABJNI
ALMA_UNASSIGNED_HOLDINGS
DIK
JSF
KQ8
MOJWN
OK1
RJT
AAYXX
CITATION
ID FETCH-LOGICAL-c1914-7eeee8464c74a7cad205e8b79c7b9d9260fb4754360414cca0b89a83b99440e73
ISSN 0916-1139
IngestDate Tue Jul 01 03:31:15 EDT 2025
Wed Sep 03 06:28:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 4
Language English
License http://www.elsevier.com/tdm/userlicense/1.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1914-7eeee8464c74a7cad205e8b79c7b9d9260fb4754360414cca0b89a83b99440e73
OpenAccessLink https://www.jstage.jst.go.jp/article/dmpk1986/10/4/10_4_464/_article/-char/en
PageCount 6
ParticipantIDs crossref_primary_10_2133_dmpk_10_464
jstage_primary_article_dmpk1986_10_4_10_4_464_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1995
1995-00-00
PublicationDateYYYYMMDD 1995-01-01
PublicationDate_xml – year: 1995
  text: 1995
PublicationDecade 1990
PublicationTitle Drug Metabolism and Pharmacokinetics
PublicationTitleAlternate Drug Metabolism and Pharmacokinetics
PublicationYear 1995
Publisher The Japanese Society for the Study of Xenobiotics
Publisher_xml – name: The Japanese Society for the Study of Xenobiotics
References 1) Neri, R. O., Florance, K., Koziol, P. and Van Cleave, S.: A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4'-nitro-3'-trifiuoro-methylisobutylanilide). Endocrinology, 91: 427-437 (1972).
3) Stolian, B. and Albert, J. A.: SCH 13521 in the treatment of advanced carcinoma of the prostate. J. Urol., 111: 803-807(1974).
2) Neri, R.O. and Monahan, M.: Effects of a novel nonsteroidal antiandrogen on canine prostatic hyperplasia. Invest. Urol., 10: 123-130 (1972).
5) 和田 浩,太田隆雄,西村千尋,根田公一,中森浩太: FLUTAMIDE の雄ラットにおける52週間経口投与毒性試験および回復性試験.応用薬理,45(2): 141-162 (1993
4) 浅川紀子,小山道則,橋本 豊,江角凱夫,高市松夫,関 英昌,原田朋子,本多尚子: 前立腺癌治療薬 FLUTAMIDE の体内動態(第2報): ラットにおける単回経口投与後の吸収,分布,排泄および全身オートラジオグラフィー.薬物動態,10(4): 456-465 (1995
References_xml – reference: 3) Stolian, B. and Albert, J. A.: SCH 13521 in the treatment of advanced carcinoma of the prostate. J. Urol., 111: 803-807(1974).
– reference: 5) 和田 浩,太田隆雄,西村千尋,根田公一,中森浩太: FLUTAMIDE の雄ラットにおける52週間経口投与毒性試験および回復性試験.応用薬理,45(2): 141-162 (1993).
– reference: 4) 浅川紀子,小山道則,橋本 豊,江角凱夫,高市松夫,関 英昌,原田朋子,本多尚子: 前立腺癌治療薬 FLUTAMIDE の体内動態(第2報): ラットにおける単回経口投与後の吸収,分布,排泄および全身オートラジオグラフィー.薬物動態,10(4): 456-465 (1995).
– reference: 2) Neri, R.O. and Monahan, M.: Effects of a novel nonsteroidal antiandrogen on canine prostatic hyperplasia. Invest. Urol., 10: 123-130 (1972).
– reference: 1) Neri, R. O., Florance, K., Koziol, P. and Van Cleave, S.: A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4'-nitro-3'-trifiuoro-methylisobutylanilide). Endocrinology, 91: 427-437 (1972).
SSID ssj0003236045
Score 1.2330022
Snippet Pharmacokinetic studies of Flutamide were performed in rats. Blood and plasma levels, tissue distribution and excretion of Flutamide were examined during and...
SourceID crossref
jstage
SourceType Index Database
Publisher
StartPage 464
SubjectTerms Antiandrogen
Antitumor agent
Concentration of radioactivity
Consecutive oral administration
Distribution
Excretion
Flutamide
Rats
Title Studies on the Metabolic Fate of Flutamide (3) : Absorption, Distribution and Excretion following Consecutive Oral Administration in Rats
URI https://www.jstage.jst.go.jp/article/dmpk1986/10/4/10_4_464/_article/-char/en
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Drug Metabolism and Pharmacokinetics, 1995, Vol.10(4), pp.464-469
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbK4IEXBALEuMkPqwQqGbk4cYzEQ7Wu6qhKJdaJ7qmKc5FK12RaGw3xD_hx_CfOsV03nfYw6IPVxD5x6_PFl-NzPhNywAopfImuUizzHSYC5iSBkI5X8FCInCd5hPHOo6_R4Ix9mYbTVutPw2upXsvD9NetcSX_o1W4B3rFKNl_0Kx9KNyA76BfSEHDkN5Jx8YJ0Bj8O6N8DSpF1up-onf_-1B7skQSSJxJolFVGQLlqrpSXYXqcZA615x6pbYSjn-mGNqoXBAvLqpr7RlQrvK0Vn5GY4zp3yXdRavJt0STQm2muufJooanrupO1j4K23Fvncw77aDXmeYlcj8hU-zS_GJzUEc2t05kFoin3WH3e9dsMc0XlR0hxue4O2A8_-clZFqIdk8HJ6PxZKzGF2iBhR17UAYyJ0pwWNXXydbsgWHkTculFzmepzmQbCfuNsDKGj0y0yTpZnBn-lyYm-OG76Fdu58tLxeHcGllmuzcN0ZN68sIqygUn6HwDC5A-B6573PuoYdp72RoTX6BH0SuOjbb_gUdMYryHxuV78yRHvyAZcLGxVDNeiaPySOzXKFdjb0npJWXT8lvgztalRRwRy3uKOKOVgXd4o6-C95_olvEfaBNvFHQOrV4oxZvtIE3iniju3ij85Ii3p6Rs_7x5GjgmCM9nBSJBB2ewwemvCzlLOFpkvlumMeSi5RLkQlYXBeS8ZBhQ3kMehdXxiKJAykEY27Og-dkr6zK_AWhYZYWsLwvwiyKGcuEdLOIZTySXgBZQu6Tg00jzi41c8vsFl3tk8-6gW0h8zqrQp6II1VQJ1DeZmNUJHRCL-9WzSvyUJMhoPHuNdlbX9X5G5jOruVbBZK_y_CldA
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Studies+on+the+Metabolic+Fate+of+Flutamide.+%283%29%3A+Absorption%2C+Distribution+and+Excretion+following+Consecutive+Oral+Administration+in+Rats&rft.jtitle=Yakubutsu+d%C5%8Dtai+%3D+Xenobiotic+metabolism+and+disposition&rft.au=ASAKAWA%2C+Noriko&rft.au=KOYAMA%2C+Michinori&rft.au=HASHIMOTO%2C+Yutaka&rft.au=YAMASHITA%2C+Kouwa&rft.date=1995&rft.issn=0916-1139&rft.volume=10&rft.issue=4&rft.spage=464&rft.epage=469&rft_id=info:doi/10.2133%2Fdmpk.10.464&rft.externalDBID=n%2Fa&rft.externalDocID=10_2133_dmpk_10_464
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0916-1139&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0916-1139&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0916-1139&client=summon